Home » Health & Medicine, Pharmaceuticals & Biotech, Science, Technology » Worldwide Business with kathy ireland® Explores the New Face of Cancer Treatment with Oxis Biotech
Tune in to Bloomberg International on Saturday, June 23-24, 2016 and Fox Business Network as sponsored programming on Sunday, July 24, 2016. See market-by-market listings below.

(Los Angeles, CA, July 19, 2016) Worldwide Business with kathy ireland® announces an exclusive story featuring Oxis Biotech (OTCQB: OXIS and Euronext Paris: OXI.PA), an immuno-oncology focused company developing innovative drugs focused on the treatment of cancer and other unmet medical needs.

Tony Cataldo, CEO of Oxis Biotech, spoke with Kathy Ireland about the revolutionary and disruptive technologies the company is developing that are well suited to make major inroads in the fight to treat and cure varied types of cancers.

The innovative new technologies that are being created and commercialized by Oxis Biotech are designed to specifically target cancer cells and begin to kill them off within the system. Non-Hodgkin’s Lymphoma is one of the deadliest types of cancer but early human clinical trials of Oxis Biotech’s OXS-1550 have shown success. The drug targets cancer cells by expressing either the CD19 or CD22 receptor or both. The cancer cells then take the drug in and are killed off by it.

“The ability to deliver targeted immunotherapy to a patient, could eliminate the use of chemotherapy,” stated Cataldo.

He adds, “Oxis is presently little known to the publicly traded markets. Being featured on Worldwide Business with kathy ireland® allows Oxis to be introduced to a wide market helping to put the achievements of Oxis front and center.”

JL Haber, Vice President of Programming for Worldwide Business with kathy ireland®, added , “Oxis Biotech is working to insure that every patient is given the chance at life and the chance to have effective cancer treatment.”

Oxis Biotech is currently working on a wide range of drugs that target a wide range of cancers like triple negative breast cancer, multiple myeloma, and more. The face of cancer treatment is changing for the better and Oxis Biotech is at the forefront.

To learn more about Oxis Biotech, tune in to Worldwide Business with kathy ireland® on Bloomberg International on Saturday, June 23, 2016 at 7:30am GMT and Sunday, June 24, 2016 at 10:30am D.F. and 3:30pm HKT and on Fox Business Network as part of their sponsored programming on Sunday, July 24, 2016 at 12:30pm EST.

About Worldwide Business with kathy ireland®

Worldwide Business with kathy ireland® is a weekly business television program featuring real-world insights from corporate executives from all over the globe which can be viewed on Fox Business Network as part of their sponsored programming lineup, as well as internationally to over 50 countries on Bloomberg International

Visit www.tvwwb.com for detailed airing schedules or check your local listings.

Distributed by Worldwide Business with kathy ireland®

Media Contact
Company Name: Worldwide Business with kathy ireland
Contact Person: Gila Stern | Communications Director
Email: gstern@productiondivison.com
Phone: 561-988-8550 x269
Country: United States
Website: www.tvwwb.com

Comments are closed.